|
Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)
|
03 April 2023 |
|
Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors
|
05 March 2019 |
|
Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin
|
20 February 2019 |
|
Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease
|
08 November 2018 |
|
Addressing social and cultural drivers of type 2 diabetes is key to its treatment and prevention
|
02 October 2018 |
|
Novo Nordisk announces plans to transform its approach to Research & Development
|
19 September 2018 |
|
Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins
|
17 August 2018 |
|
Kallyope and Novo Nordisk announce collaboration to discover novel therapeutics for obesity and diabetes
|
19 June 2018 |
|
Novo Nordisk increases commitment to stem cell-based therapies
|
16 May 2018 |
|
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes
|
02 May 2018 |